Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.89 USD | -2.83% | 0.00% | -16.82% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 35.04M |
---|---|---|---|---|---|
Net income 2024 * | -27M | Net income 2025 * | -34M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.87
x | P/E ratio 2025 * |
-1.55
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 25.21% |
Latest transcript on MiNK Therapeutics, Inc.
1 day | -2.83% | ||
Current month | -6.24% | ||
1 month | -8.25% | ||
3 months | -5.32% | ||
6 months | -18.35% | ||
Current year | -16.82% |
Managers | Title | Age | Since |
---|---|---|---|
Jennifer Buell
CEO | Chief Executive Officer | 49 | 21-01-31 |
Heather Boussios
CMP | Compliance Officer | - | - |
Marc van Dijk
CTO | Chief Tech/Sci/R&D Officer | 61 | 20-02-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Garo Armen
CHM | Chairman | 71 | 17-06-30 |
Director/Board Member | 66 | 17-06-30 | |
Barbara Ryan
BRD | Director/Board Member | 64 | 21-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-07-02 | 0.89 | -2.83% | 19,884 |
24-07-01 | 0.9159 | -3.51% | 32,493 |
24-06-28 | 0.9492 | +2.06% | 38,238 |
24-06-27 | 0.93 | +4.49% | 31,147 |
24-06-26 | 0.89 | 0.00% | 21,465 |
Delayed Quote Nasdaq, July 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.82% | 35.04M | |
+17.72% | 44.87B | |
-10.33% | 37.8B | |
+41.16% | 37.61B | |
+29.36% | 31.32B | |
-8.44% | 27.4B | |
+12.45% | 26.32B | |
+44.19% | 14.07B | |
+31.93% | 12.5B | |
-7.67% | 11.23B |
- Stock Market
- Equities
- INKT Stock